Globus Medical ROA 2010-2018 | GMED
Current and historical return on assets (ROA) values for Globus Medical (GMED) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Globus Medical ROA for the three months ending June 30, 2018 was 13.74%.
| Globus Medical Annual ROA | |
|---|---|
| 2017 | 9.95 |
| 2016 | 11.25 |
| 2015 | 13.52 |
| 2014 | 13.15 |
| 2013 | 12.12 |
| 2012 | 16.51 |
| 2011 | 18.45 |
| 2010 | 20.43 |
| 2009 | 0.00 |
| Globus Medical Quarterly ROA | |
|---|---|
| Q2 2018 | 3.77 |
| Q1 2018 | 3.51 |
| Q4 2017 | 2.26 |
| Q3 2017 | 2.47 |
| Q2 2017 | 2.88 |
| Q1 2017 | 2.99 |
| Q4 2016 | 2.62 |
| Q3 2016 | 2.91 |
| Q2 2016 | 2.97 |
| Q1 2016 | 3.34 |
| Q4 2015 | 4.51 |
| Q3 2015 | 3.31 |
| Q2 2015 | 3.15 |
| Q1 2015 | 3.31 |
| Q4 2014 | 3.93 |
| Q3 2014 | 3.57 |
| Q2 2014 | 3.34 |
| Q1 2014 | 3.53 |
| Q4 2013 | 3.71 |
| Q3 2013 | 3.87 |
| Q2 2013 | 1.49 |
| Q1 2013 | 4.20 |
| Q4 2012 | 4.65 |
| Q3 2012 | 3.96 |
| Q2 2012 | 5.17 |
| Q1 2012 | 4.95 |
| Q4 2011 | 4.12 |
| Q3 2011 | 0.00 |
| Q2 2011 | 0.00 |
| Q1 2011 | 0.00 |
| Q4 2010 | 0.00 |
| Q4 2009 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.316B | $0.636B |
| Globus Medical, Inc. is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders. The Company's products fall into one of two categories: innovative fusion or disruptive technologies. Its innovative fusion products address a broad range of spinal fusion surgical procedures. Its disruptive technology products include minimally invasive surgical, motion preservation and advanced biomaterials technologies. Globus Medical, Inc. is based in Audubon, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $98.077B | 23.53 |
| Intuitive Surgical (ISRG) | United States | $63.331B | 60.45 |
| Edwards Lifesciences (EW) | United States | $32.178B | 36.24 |
| Fresenius Medical Care (FMS) | Germany | $31.319B | 22.12 |
| IDEXX Laboratories (IDXX) | United States | $20.880B | 63.46 |
| ABIOMED (ABMD) | United States | $17.272B | 141.50 |
| Teleflex (TFX) | United States | $12.353B | 29.39 |
| DexCom (DXCM) | United States | $12.326B | 0.00 |
| Hologic (HOLX) | United States | $11.222B | 19.09 |
| Varian Medical Systems (VAR) | United States | $10.297B | 25.92 |
| STERIS (STE) | United Kingdom | $9.636B | 26.50 |
| Masimo (MASI) | United States | $6.344B | 42.24 |
| LivaNova (LIVN) | United Kingdom | $5.944B | 35.46 |
| Inogen (INGN) | United States | $5.438B | 143.90 |
| Integra LifeSciences Holdings (IART) | United States | $5.381B | 27.85 |
| Penumbra (PEN) | United States | $5.135B | 466.72 |
| Cantel Medical (CMD) | United States | $4.058B | 42.30 |
| Halyard Health (AVNS) | United States | $3.231B | 26.59 |
| Wright Medical Group (WMGI) | Netherlands | $2.988B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.683B | 24.29 |
| Opko Health (OPK) | United States | $2.418B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.320B | 0.00 |
| Glaukos (GKOS) | United States | $2.054B | 1176.80 |
| Nevro (NVRO) | United States | $1.784B | 0.00 |
| Mazor Robotics (MZOR) | Israel | $1.531B | 0.00 |
| AxoGen (AXGN) | United States | $1.374B | 0.00 |
| Luminex (LMNX) | United States | $1.309B | 38.62 |
| CryoLife (CRY) | United States | $1.272B | 111.61 |
| Accelerate Diagnostics (AXDX) | United States | $1.221B | 0.00 |
| K2Ms (KTWO) | United States | $1.190B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.172B | 199.72 |
| Natus Medical (BABY) | United States | $1.152B | 24.43 |
| Orthofix (OFIX) | United States | $1.017B | 30.97 |
| Intersect ENT (XENT) | United States | $0.901B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.872B | 32.21 |
| ViewRay (VRAY) | United States | $0.733B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.698B | 43.16 |
| Sientra (SIEN) | United States | $0.692B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.635B | 0.00 |
| Neuronetics (STIM) | United States | $0.603B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.438B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.418B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.415B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.360B | 0.00 |
| IRadimed (IRMD) | United States | $0.357B | 128.65 |
| Accuray (ARAY) | United States | $0.355B | 0.00 |
| Veracyte (VCYT) | United States | $0.346B | 0.00 |
| Nuvectra (NVTR) | United States | $0.320B | 0.00 |
| Fluidigm (FLDM) | United States | $0.308B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.282B | 55.63 |
| T2 Biosystems (TTOO) | United States | $0.277B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.234B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.234B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.228B | 0.00 |
| Invuity (IVTY) | United States | $0.178B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.151B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.138B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.138B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.125B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.124B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.120B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.094B | 0.00 |
| EDAP TMS (EDAP) | France | $0.083B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.077B | 0.00 |
| ConforMIS (CFMS) | United States | $0.075B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.061B | 0.00 |
| Neovasc (NVCN) | Canada | $0.057B | 0.00 |
| Vermillion (VRML) | United States | $0.053B | 0.00 |
| PAVmed (PAVM) | United States | $0.035B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.032B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.032B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.031B | 0.00 |
| Presbia (LENS) | Ireland | $0.030B | 0.00 |
| Dynatronics (DYNT) | United States | $0.023B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.020B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.020B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.017B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.017B | 0.00 |
| Avinger (AVGR) | United States | $0.016B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.013B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.009B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.008B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.008B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.008B | 0.00 |
| Amedica (AMDA) | United States | $0.003B | 0.00 |
| EnteroMedics (RSLS) | United States | $0.000B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
